Genkyotex Meets Both Primary and Secondary Interim Efficacy Endpoints in Phase 2 Trial of GKT831 in Primary Biliary Cholangitis Read more
BioTime and Asterias Enter Into Definitive Merger Agreement to Create Leading Cell Therapy Company Read more
Hikma announces global agreement with Vectura to develop generic versions of GSK’s Ellipta portfolio Read more
Guided Therapeutics Announces Extension of Distribution Agreement for Eastern Europe and Russia Read more